FEMA ADVISORY – May 21, 2020
Coronavirus (COVID-19) Pandemic: Whole-of-America Response
Attached you will find today’s FEMA Daily Briefing Points for the Whole-of-America response to the coronavirus (COVID-19) pandemic. These briefing points include Topline Messages, as well as information By the Numbers; Supply Chain Task Force; FEMA and Department of Health and Human Services Response; and Guidance from Federal Agencies.
Topline messaging includes:
- On May 21, HHS announced a collaboration between the company AstraZeneca and the Biomedical Advanced Research and Development Authority (BARDA) to accelerate the development and manufacturing of an investigational vaccine, AZD1222. HHS and AstraZeneca will make at least 300 million doses of the vaccine, the first of which will be delivered as early as this October.
- Phase 3 clinical studies are set to begin this summer.
- This vaccine is the fourth vaccine candidate to receive BARDA support for late-state development and manufacturing under Operation Warp Speed.
- The guide describes anticipated challenges to disaster operations posed by COVID-19, as well as actions emergency managers and public officials can take to prepare for those challenges.
- By creating a shared understanding of expectations among FEMA and state, local, tribal and territorial partners prior to hurricane season, the nation will be better positioned to achieve operational outcomes in disaster response and recovery efforts.
- On May 20, the Health Resources and Services Administration announced $225 million in funding through the Paycheck Protection Program and Health Care Enhancement Act to Rural Health Clinics for COVID-19 testing. These investments will support over 4,500 Rural Health Clinics across the country with expanding access to testing in rural communities.
- As of May 20, FEMA, HHS, and the private sector combined have coordinated the delivery of or are currently shipping: 83.8 million N95 respirators, 138.5 million surgical masks, 11.9 million face shields, 26.9 million surgical gowns, and 1 billion gloves.
- FEMA has procured and delivered 7 million swabs and 3.9 million units of media so far in the month of May. In support of the White House Task Force’s testing initiative, FEMA is procuring specimen collection supplies to supplement the supplies states and healthcare providers are procuring from the private market.
- As of May 20, CDC, state, and local public health labs and other laboratories have tested more than 12.6 million samples.
- As of May 20, the FDA has issued 105 individual emergency use authorizations (EAU) for test kit manufacturers and laboratories, including 12 antibody tests and 1 antigen test.
If you have any questions regarding this FEMA Advisory, please contact FEMA Office of External Affairs, Congressional and Intergovernmental Affairs Division:
Follow FEMA on social media at: Visit the FEMA Blog, follow @FEMA or @FEMAEspanol on Twitter, FEMA or FEMA Espanol on Facebook, @FEMA on Instagram, and view videos on the FEMA YouTube channel, and Administrator Pete Gaynor on Twitter @FEMA_Pete.
To help people before, during and after disasters.